Summary
Overview
Work History
Education
Skills
Affiliations
Publications
Accomplishments
References
Timeline
Generic

Muhammad Raza Naqvi

Denver,Colorado

Summary

Most Compassionate Physician 2016 and 2017 Physician Choice Award by Patients CNY. Unsung Hero Award 2012(Medicine Residency 2009-2012). Resident of the Year 2011. Awarded third best graduate of class of 2003 at Punjab Medical College Pakistan Awarded distinction in Biology GCSE A LEVELS 2001
Awarded distinction in Pharmacology in second professional examinations held under University of Health Sciences Lahore. Pakistan Awarded Class top Position in Anatomy and Biochemistry in first professional examination.

Overview

15
15
years of professional experience

Work History

Consultant Medical Oncologist

Intermountain Healthcare
12.2023 - Current
  • Skilled at working independently and collaboratively in a team environment.
  • Self-motivated, with a strong sense of personal responsibility.
  • Worked well in a team setting, providing support and guidance.
  • Excellent communication skills, both verbal and written.

Medical Director

ZahRaza Oncology Associates
11.2022 - Current

TeleMedicine Oncology Service to the Underserved Population of the United States.

Speaker

Bristol Myers Squibb
04.2020 - Current

Senior Consultant Medical Oncology

Team Lead in Oncology in the Interdisciplinary Cases for optimal patient management in accordance with NCCN guidelines.


Medical Oncologist/Hematologist

Adventist Health System
11.2022 - 11.2023

Active Participant in Multidisciplinary care for patients.

Specialized in in GI and GU Oncology.

Active Participation in Tumor Boards.

Work Closely with Nurse Navigation to improve patient satisfaction.

Personally monitor teaching and administration of chemotherapy.

Manage Patient flow systems and improved patient satisfation by 15 %

Cancer Treatment , Cancer Immunotherapy , Clinical Industry Research , use of Biologics, Treatment Planning in Multi D Settings

Medical Oncologist

Oncology San Antonio
06.2019 - 11.2022
  • Directed work of administrative, nursing and operations team members.
  • Determined appropriate treatments for Cancer Patients.
  • Implemented therapeutic regiments involving medications and other interventions to mitigate symptoms and prevent reoccurrence.
  • Maintained high patient satisfaction through knowledgeable support and compassionate care.
  • Ordered and executed various tests, analyses and diagnostic images to provide information on patient condition.
  • Reviewed medical testing requests to determine validity of diagnostic testing requests.

Medical Oncology Director Urologic Oncology

Upstate Medical University
07.2015 - 05.2019

Also Heading the Head and Neck Oncology Section

Assistant Professor

SUNY Upstate University Hospital
09.2015 - 05.2019
  • Instructed students using lectures, discussions and demonstrations in Medical Oncology and Hematology.
  • Involved with Clinical Trial Designs.
  • PI on many Clinical Trials both Cooperative Groups and Industry.

Fellowship Physician Hematology Oncology

University of New Mexico
07.2012 - 07.2015

Chief Fellow 2014-2015

Chief Fellow

01.2014 - 01.2015

Resident Physician

University of New Mexico
06.2009 - 06.2012

  • Presented Case report at ACP NM Chapter.
  • Presented original Basic Science research Project at Scientific Session Carmel California.

Education

Residency Internal Medicine - Internal Medicine

University of New Mexico
Albuquerque, NM
2012

M.D - Internal Medicine

Rawalpindi Medical College

M.B.B.S.Undergraduate -

University of New Mexico
Albuquerque, NM
2007

Advanced Levels Degree -

Rawalpindi Medical College, University of Cambrdige
2001

Magma College of Advanced StudiesUniversity of Cambridge - Islamabad

Skills

  • Chronic and acute pain management
  • Medical research comprehension
  • Hospice and Palliative Care
  • Bone Marrow Aspiration and Biopsy

Affiliations

Medical Board of New Mexico American Board of Internal Medicine 329455  Member American Board of Oncology   ASCO Member ASH Member ACP Member PMDC Medical Oncology Liaison for Palliative Care at Upstate Cancer Center Member Scientific Review Committee( Involved in Monthly review of the new Clinical Trials that are considered to be opened at Cancer Center) ​

Publications

Peer Reviewed Journal Articles/Abstracts Abbas,S ,Naqvi,Muhammad Raza.,Khan,A. Aerobiology of allergenic plants of Islamabad. Pakistan Journal of Medical Research. Publication Status: Published .  Othman Muhammad , Naqvi,Muhammad Raza :Attendance Rates of Colonoscopy amongst various ethnic groups"Status submitted to Journal of Gastrointestinal Endoscopy"  Muhammad Raza Naqvi :Molecular processes involved in LPS induced increase in intestinal TJ permeability " Presented at Research Conference in Carmel 2011. Muhammad Raza Naqvi:LPS induces activation of p38 kinase dependent transcription factors NF-kappa B,ATF-2, MEF-2 and Elk1 " Presented at Research Conference in Carmel 2011.​Poster Presentation Abbas,S.,Khan,A., Muhammad Raza Naqvi., Katelaris,C., Sigh,B., Boltano,J.,. (2007, December). Aerobiology of Allergenic Plants of Islamabad. Poster presented at: World Allergy Organisation Congress; Bangkok, Thailand. Oral Presentation Muhammad Raza Naqvi" Sutton's Law and an unusual case of Lymphadenopathy" ACP meeting New Mexico Chapter in October 2010.  Muhammad Raza Naqvi " LPS induced increase in Intestinal Tight Junction Memberane Permeability" Western Regional Conference Carmel, California in Jan 2011.  Muhammad Raza Naqvi.,Raqeem,W. (2006, March). In Chronic HBV Patients with Raised ALT Level, the Presence of HBeAg Should Be Considered a Surrogate Marker of HBV DNA. Oral Presentation presented at: Pakistan Society of Gastroenterology Workshop; Rawalpindi, Pakistan May 2005 (2nd Prize).  

Accomplishments

  • PI for AFT-19-A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer .
  • PI for AFT-28: Direct Oral Anticoagulants (DOACs) versus LMWH +/- Warfarin for VTE in Cancer: A Randomized Effectiveness Trial (CANVAS Trial)
  • PI for BioClin Protocol B-701-U21 - A Phase 1b/2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study of B-701 Plus Docetaxel Versus Placebo Plus Docetaxel in the Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma in Subjects who have Relapsed After, or are Refractory to Standard Therapy
  • A Phase III Study of Pembrolizumab (MK-3475) vs. Best Supportive Care as Second-Line Therapy in Subjects with Previously Systemically Treated Advanced Hepatocellular Carcinoma (KEYNOTE-240) WO39210 - A PHASE III, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY

References

 Stephen Graziano, MD Hematology/Oncology  Upstate University Hospital Division Chief grazianos@upstate.edu    Sam Benjamin  MD Department of Hematology/Oncology  Upstate University Hospital Program Director benjamins@upstate.edu

Timeline

Consultant Medical Oncologist

Intermountain Healthcare
12.2023 - Current

Medical Director

ZahRaza Oncology Associates
11.2022 - Current

Medical Oncologist/Hematologist

Adventist Health System
11.2022 - 11.2023

Speaker

Bristol Myers Squibb
04.2020 - Current

Medical Oncologist

Oncology San Antonio
06.2019 - 11.2022

Assistant Professor

SUNY Upstate University Hospital
09.2015 - 05.2019

Medical Oncology Director Urologic Oncology

Upstate Medical University
07.2015 - 05.2019

Chief Fellow

01.2014 - 01.2015

Fellowship Physician Hematology Oncology

University of New Mexico
07.2012 - 07.2015

Resident Physician

University of New Mexico
06.2009 - 06.2012

Residency Internal Medicine - Internal Medicine

University of New Mexico

M.D - Internal Medicine

Rawalpindi Medical College

M.B.B.S.Undergraduate -

University of New Mexico

Advanced Levels Degree -

Rawalpindi Medical College, University of Cambrdige

Magma College of Advanced StudiesUniversity of Cambridge - Islamabad
Muhammad Raza Naqvi